Monthly Archives: April 2011

T&T targets new investor strategy

Along with its business opportunities, Trinidad and Tobago has committed to an open, market-driven economy, fuelled by trade liberalisation and both local and foreign investment. Its strategic location makes it a gateway to the Americas; and natural resources, a highly-educated labour force, excellent infrastructure developments and a pro-investment climate continue to attract business. The country…

Emerging market tonic for pharmas

Pfizer, GlaxoSmithKline, Procter & Gamble, Astra Zeneca and Johnson & Johnson are among the immediately recognisable global brand names in the pharmaceuticals industry. Due to the non-cyclical nature of the industry, pharmaceuticals companies were some of the most likely to have prospered during the economic crisis, and the industry is expected to grow by five…

Wind power becomes mainstream

Vestas, as the market leader, is taking wind power to new, unprecedented heights. Solid financial results for Vestas, in a testing year, have helped confirm wind as the leading source of renewable energy. Vestas’ order intake in 2010 increased by 182 percent, rising from 3,072 to 8,673 MW, the highest in the company’s, and the…

Wealth manager targets innovation

The investment management area of Banif, the Portuguese financial group, has been establishing a successful track record in terms of Growth and Innovation. Banif Investment Managers (BIM) recorded strong growth in 2010, with assets under management (in mutual funds, real estate funds, alternative asset funds, pension funds and other managed portfolios) reaching €4bn in December…

Apple files patent suit against Samsung

Apple has filed a lawsuit against South Korean electronics group Samsung alleging its mobile phones and tablet computer are a copy of its iPhone and iPad. The case against Samsung was filed by Apple on Friday at the US District Court for the Northern District in California but details were not released until Tuesday when the…

Synthes reports merger talks with Johnson & Johnson

Swiss medical device manufacturer Synthes said on Monday it is in preliminary takeover talks with health conglomerate Johnson & Johnson.  The deal could be worth up to $20bn and if completed would be one of the largest healthcare takeover deals in recent years, according to sources familiar with the process. The company said in a statement:…

How to Buy a Kit Home

Kit homes are rapidly increasing in popularity across the globe, especially in Australia.  It is important to consider how to actually buy a kit home though, as they are not the same as regular houses – the buying process is slightly different.Why are they so popular?The main reason for the growth of the kit home…

Nestlé sales fall 9% but growth up 6.4%

Nestlé, the world’s biggest food group by sales, saw a 9 percent drop in Q1 sales to CHF22.26bn compared to CHF22.34bn the previous year, the company announced on Friday. The decrease in sales were due to the sale of its Alcon eye care business and foreign exchange rates by the Swiss franc which has been trading…

Glencore to float stock worth up to $11bn

Glencore, the world’s largest commodities trading group by revenue intends to sell between $9bn-11bn in shares in its IPO on the Hong Kong and London stock exchanges, the Swiss company announced on Thursday. The group will use in the next three years around $5bn of the profits from the IPO for capital expenditure and around…